Age and gender adjusted incidence of RRT for ESRD due to DN per million population during the period 2000–2012 in the Netherlands
| Year | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cause | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | APC % (95% CI) |
| All | 102.5 | 105.8 | 108.9 | 109.9 | 112.3 | 113.7 | 117.7 | 119.1 | 124.8 | 121.3 | 119.1 | 116.9 | 117.6 | 2000–2008: 2.2 (1.9 to 2.5) 2008–2012: −1.3 (−2.1 to −0.5) |
| Non-DN | 63.9 | 67.7 | 70.2 | 74.6 | 73.5 | 72.0 | 73.5 | 74.0 | 78.3 | 78.9 | 72.0 | 71.0 | 70.0 | 2000–2008: 2.0 (0.8 to 3.2) 2008–2012: −2.8 (−6.0 to 0.5) |
| Unknown/missing | 21.2 | 20.2 | 19.5 | 16.8 | 18.7 | 23.1 | 24.5 | 22.7 | 23.8 | 23.8 | 28.2 | 26.0 | 28.5 | 2000–2012: 3.4 (1.8 to 5.0) |
| DN both | 17.4 | 17.9 | 19.2 | 18.6 | 20.2 | 18.6 | 19.7 | 22.3 | 22.7 | 18.6 | 18.9 | 19.9 | 19.1 | 2000–2012: 0.8 (−0.4 to 2.0) |
| T1DN | 7.3 | 6.5 | 5.4 | 5.8 | 5.9 | 5.9 | 5.9 | 5.4 | 5.0 | 3.6 | 4.5 | 4.4 | 3.5 | 2000–2012: −4.8 (−6.5 to −3.1) |
| T2DN | 10.1 | 11.5 | 13.8 | 12.7 | 14.2 | 12.7 | 13.7 | 17.0 | 17.7 | 15.0 | 14.4 | 15.4 | 15.6 | 2000–2012: 3.1 (1.3 to 4.8) |
Categories may not add up because of rounding off.
APC, annual percentage change; DN, diabetic nephropathy; ESRD, end-stage renal disease; RRT, renal replacement therapy; T1DN, type 1 DN; T2DN, type 2 DN.